{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-038060","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.696881+00:00","generated_at":"2026-05-22T23:46:44.671878+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ABVC BioPharma Q1 net loss narrows 68% to $944K; eyes AI agriculture in Taiwan","bullets":["Net loss per share improved to $(0.06) from $(0.29) in Q1 2024.","Total operating expenses reduced 76% to $693,005.","Net loss attributable to ABVC was $842,075, down from $2.83M.","Recognized a land asset in Taiwan valued at $7.67M for potential AI-integrated GAP-compliant plant factory.","Company evaluating development of AI-driven agricultural facility for sustainable botanical supply chain."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-038060","json":"https://secwatch.observer/filing/0001213900-25-038060.json","markdown":"https://secwatch.observer/filing/0001213900-25-038060.md","text":"https://secwatch.observer/filing/0001213900-25-038060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390025038060/0001213900-25-038060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390025038060/ea0240063-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T23:46:44.671878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}